WallStreetZenWallStreetZen

NASDAQ: ELUT
Elutia Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ELUT

Based on 1 analyst offering 12 month price targets for Elutia Inc

Min Forecast
$6.00+560.07%
Avg Forecast
$6.00+560.07%
Max Forecast
$6.00+560.07%

Should I buy or sell ELUT stock?

Based on 1 analyst offering ratings for Elutia Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ELUT stock forecasts and price targets.

ELUT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-10

1 of 1

Forecast return on equity

Is ELUT forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is ELUT forecast to generate an efficient return on assets?

Company
-62.6%
Industry
11.35%
ELUT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ELUT earnings per share forecast

What is ELUT's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.64
Avg 2 year Forecast
-$0.57
Avg 3 year Forecast
-$0.50

ELUT revenue forecast

What is ELUT's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$24.8M+4.87%
Avg 2 year Forecast
$26.4M+11.55%
Avg 3 year Forecast
$18.8M-20.75%
ELUT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ELUT revenue growth forecast

How is ELUT forecast to perform vs Medical Devices companies and vs the US market?

Company
-0.38%
Industry
7.5%
Market
58.18%
ELUT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ELUT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ELUT vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
ELUT$0.91$6.00+560.07%Strong Buy
ECOR$5.04N/AN/A
NMTC$0.79$2.23+180.93%Strong Buy
ICCM$0.71$2.50+250.63%Buy
MYO$0.93$7.83+745.90%Buy
View Top Medical Device Stocks

Elutia Stock Forecast FAQ

Is Elutia Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ELUT) stock is to Strong Buy ELUT stock.

Out of 1 analyst, 1 (100%) are recommending ELUT as a Strong Buy, 0 (0%) are recommending ELUT as a Buy, 0 (0%) are recommending ELUT as a Hold, 0 (0%) are recommending ELUT as a Sell, and 0 (0%) are recommending ELUT as a Strong Sell.

If you're new to stock investing, here's how to buy Elutia stock.

What is ELUT's earnings growth forecast for 2025-2027?

(NASDAQ: ELUT) Elutia's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 16.39%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 101.51%.

Elutia's earnings in 2025 is -$21,537,000.On average, 4 Wall Street analysts forecast ELUT's earnings for 2025 to be -$27,027,030, with the lowest ELUT earnings forecast at -$28,252,255, and the highest ELUT earnings forecast at -$25,373,612. On average, 4 Wall Street analysts forecast ELUT's earnings for 2026 to be -$24,216,219, with the lowest ELUT earnings forecast at -$26,174,884, and the highest ELUT earnings forecast at -$21,812,403.

In 2027, ELUT is forecast to generate -$21,189,191 in earnings, with the lowest earnings forecast at -$20,358,243 and the highest earnings forecast at -$21,812,403.

What is ELUT's revenue growth forecast for 2025-2027?

(NASDAQ: ELUT) Elutia's forecast annual revenue growth rate of -0.38% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.18%.

Elutia's revenue in 2025 is $23,683,000.On average, 4 Wall Street analysts forecast ELUT's revenue for 2025 to be $1,052,973,084, with the lowest ELUT revenue forecast at $897,424,578, and the highest ELUT revenue forecast at $1,206,359,428. On average, 4 Wall Street analysts forecast ELUT's revenue for 2026 to be $1,120,000,119, with the lowest ELUT revenue forecast at $614,902,026, and the highest ELUT revenue forecast at $1,647,058,998.

In 2027, ELUT is forecast to generate $795,675,760 in revenue, with the lowest revenue forecast at $764,472,789 and the highest revenue forecast at $819,077,988.

What is ELUT's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: ELUT) forecast ROA is -62.6%, which is lower than the forecast US Medical Devices industry average of 11.35%.

What is ELUT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ELUT price target, the average ELUT price target is $6.00, with the highest ELUT stock price forecast at $6.00 and the lowest ELUT stock price forecast at $6.00.

The Wall Street analyst predicted that Elutia's share price could reach $6.00 by Sep 10, 2026. The average Elutia stock price prediction forecasts a potential upside of 560.07% from the current ELUT share price of $0.91.

What is ELUT's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ELUT) Elutia's current Earnings Per Share (EPS) is -$0.51. On average, analysts forecast that ELUT's EPS will be -$0.64 for 2025, with the lowest EPS forecast at -$0.67, and the highest EPS forecast at -$0.60. On average, analysts forecast that ELUT's EPS will be -$0.57 for 2026, with the lowest EPS forecast at -$0.62, and the highest EPS forecast at -$0.51. In 2027, ELUT's EPS is forecast to hit -$0.50 (min: -$0.48, max: -$0.51).

What is ELUT's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: ELUT) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.